Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Efficacy and toxicity of antihypertensive pharmacotherapy relative to effective dose 50.

Dimmitt SB, Stampfer HG, Martin JH, Ferner RE.

Br J Clin Pharmacol. 2019 Jun 20. doi: 10.1111/bcp.14033. [Epub ahead of print] Review.

PMID:
31219198
2.

Antithrombotic dose: Some observations from published clinical trials.

Dimmitt SB, Floyd CN, Ferner RE.

Br J Clin Pharmacol. 2019 May 3. doi: 10.1111/bcp.13968. [Epub ahead of print] Review.

PMID:
31050833
3.

The relationship between antemortem and postmortem morphine concentrations.

Langford NJ, Morley SR, Ferner RE.

Clin Toxicol (Phila). 2019 Mar 23:1-4. doi: 10.1080/15563650.2019.1591430. [Epub ahead of print]

PMID:
30905172
4.

Adverse drug reactions.

Ferner RE, McGettigan P.

BMJ. 2018 Nov 6;363:k4051. doi: 10.1136/bmj.k4051. No abstract available. Erratum in: BMJ. 2018 Nov 12;363:k4777.

PMID:
30401691
5.

Preventing Future Deaths from Medicines: Responses to Coroners' Concerns in England and Wales.

Ferner RE, Ahmad T, Babatunde Z, Cox AR.

Drug Saf. 2019 Mar;42(3):445-451. doi: 10.1007/s40264-018-0738-z.

PMID:
30298309
6.

Prescribing biosimilars.

Aronson JK, Goldacre B, Ferner RE.

BMJ. 2018 Jul 24;362:k3141. doi: 10.1136/bmj.k3141. No abstract available.

PMID:
30042142
7.

Deaths from Medicines: A Systematic Analysis of Coroners' Reports to Prevent Future Deaths.

Ferner RE, Easton C, Cox AR.

Drug Saf. 2018 Jan;41(1):103-110. doi: 10.1007/s40264-017-0588-0.

PMID:
28808959
8.

Unlicensed and off-label uses of medicines: definitions and clarification of terminology.

Aronson JK, Ferner RE.

Br J Clin Pharmacol. 2017 Dec;83(12):2615-2625. doi: 10.1111/bcp.13394. Epub 2017 Sep 26. Review.

9.

The toxicological significance of post-mortem drug concentrations in bile.

Ferner RE, Aronson JK.

Clin Toxicol (Phila). 2018 Jan;56(1):7-14. doi: 10.1080/15563650.2017.1339886. Epub 2017 Jul 6. Review.

PMID:
28681613
10.

Biomarkers-A General Review.

Aronson JK, Ferner RE.

Curr Protoc Pharmacol. 2017 Mar 17;76:9.23.1-9.23.17. doi: 10.1002/cpph.19. Review.

PMID:
28306150
11.

A systematic review of the evidence for acute tolerance to alcohol - the "Mellanby effect".

Holland MG, Ferner RE.

Clin Toxicol (Phila). 2017 Jul;55(6):545-556. doi: 10.1080/15563650.2017.1296576. Epub 2017 Mar 9. Review.

PMID:
28277803
12.

PCSK9 inhibitors for hypercholesterolaemia.

McGettigan P, Ferner RE.

BMJ. 2017 Jan 19;356:j188. doi: 10.1136/bmj.j188. No abstract available.

PMID:
28104607
13.

Manslaughter trials ignore systemic failures.

Ferner RE.

BMJ. 2016 Dec 30;355:i6630. doi: 10.1136/bmj.i6630. No abstract available.

PMID:
28039121
14.

Perceptions and Impact of Mandatory eLearning for Foundation Trainee Doctors: A Qualitative Evaluation.

Brooks HL, Pontefract SK, Vallance HK, Hirsch CA, Hughes E, Ferner RE, Marriott JF, Coleman JJ.

PLoS One. 2016 Dec 22;11(12):e0168558. doi: 10.1371/journal.pone.0168558. eCollection 2016.

15.
16.

How similar are biosimilars?

Aronson JK, Ferner RE.

BMJ. 2016 May 17;353:i2721. doi: 10.1136/bmj.i2721. No abstract available.

PMID:
27188872
17.
18.

Authors' reply to Green and colleagues.

Ferner RE, Gogtay NJ.

BMJ. 2015 Dec 9;351:h6588. doi: 10.1136/bmj.h6588. No abstract available.

PMID:
26655828
19.

Mefloquine for malarial prophylaxis in military personnel.

Gogtay NJ, Ferner RE.

BMJ. 2015 Nov 3;351:h5797. doi: 10.1136/bmj.h5797. No abstract available.

PMID:
26534919
20.

Cato Guldberg and Peter Waage, the history of the Law of Mass Action, and its relevance to clinical pharmacology.

Ferner RE, Aronson JK.

Br J Clin Pharmacol. 2016 Jan;81(1):52-5. doi: 10.1111/bcp.12721. Epub 2015 Oct 22. Review.

21.

The law of mass action and the pharmacological concentration-effect curve: resolving the paradox of apparently non-dose-related adverse drug reactions.

Aronson JK, Ferner RE.

Br J Clin Pharmacol. 2016 Jan;81(1):56-61. doi: 10.1111/bcp.12706. Epub 2015 Oct 26. Review.

22.

A licence to cure.

Aronson JK, Ferner RE.

BMJ. 2015 Apr 1;350:h1723. doi: 10.1136/bmj.h1723. No abstract available.

PMID:
25834026
23.

A systematic review and meta-analysis of thiazide-induced hyponatraemia: time to reconsider electrolyte monitoring regimens after thiazide initiation?

Barber J, McKeever TM, McDowell SE, Clayton JA, Ferner RE, Gordon RD, Stowasser M, O'Shaughnessy KM, Hall IP, Glover M.

Br J Clin Pharmacol. 2015 Apr;79(4):566-77. doi: 10.1111/bcp.12499.

24.

Temporal and other factors that influence the time doctors take to prescribe using an electronic prescribing system.

Coleman JJ, Hodson J, Thomas SK, Brooks HL, Ferner RE.

J Am Med Inform Assoc. 2015 Jan;22(1):206-12. doi: 10.1136/amiajnl-2014-002822. Epub 2014 Jul 29.

25.

Fundamentals of lung auscultation.

Coleman JJ, Ferner RE.

N Engl J Med. 2014 May 22;370(21):2052. doi: 10.1056/NEJMc1403766. No abstract available.

PMID:
24849096
26.

Checklist for standardized reporting of drug-drug interaction management guidelines.

Floor-Schreudering A, Geerts AF, Aronson JK, Bouvy ML, Ferner RE, De Smet PA.

Eur J Clin Pharmacol. 2014 Mar;70(3):313-8. doi: 10.1007/s00228-013-1612-7. Epub 2013 Dec 5.

PMID:
24306496
27.

On the alert: future priorities for alerts in clinical decision support for computerized physician order entry identified from a European workshop.

Coleman JJ, van der Sijs H, Haefeli WE, Slight SP, McDowell SE, Seidling HM, Eiermann B, Aarts J, Ammenwerth E, Slee A, Ferner RE.

BMC Med Inform Decis Mak. 2013 Oct 1;13:111. doi: 10.1186/1472-6947-13-111. Erratum in: BMC Med Inform Decis Mak. 2013;13:122. Ferner, Robin E [corrected to Slee, Ann]; Slee, Ann [corrected to Ferner, Robin E].

28.

Medical manslaughter.

McDowell SE, Ferner RE.

BMJ. 2013 Sep 18;347:f5609. doi: 10.1136/bmj.f5609. No abstract available.

PMID:
24048308
29.

Effects of a computerized feedback intervention on safety performance by junior doctors: results from a randomized mixed method study.

Redwood S, Ngwenya NB, Hodson J, Ferner RE, Coleman JJ.

BMC Med Inform Decis Mak. 2013 Jun 4;13:63. doi: 10.1186/1472-6947-13-63.

30.

Harms from medicines: inevitable, in error or intentional.

Ferner RE.

Br J Clin Pharmacol. 2014 Mar;77(3):403-9. doi: 10.1111/bcp.12156. Review.

31.

A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy.

McDowell SE, Thomas SK, Coleman JJ, Aronson JK, Ferner RE.

J R Soc Med. 2013 Mar;106(3):87-95. doi: 10.1258/jrsm.2012.120137. Review. Erratum in: J R Soc Med. 2013 Apr;106(4):119.

32.

Internet accounts of serious adverse drug reactions: a study of experiences of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Butt TF, Cox AR, Oyebode JR, Ferner RE.

Drug Saf. 2012 Dec 1;35(12):1159-70. doi: 10.2165/11631950-000000000-00000.

PMID:
23058037
33.

Hypoglycemia in non-diabetic in-patients: clinical or criminal?

Nirantharakumar K, Marshall T, Hodson J, Narendran P, Deeks J, Coleman JJ, Ferner RE.

PLoS One. 2012;7(7):e40384. doi: 10.1371/journal.pone.0040384. Epub 2012 Jul 2.

34.

Dose omissions in hospitalized patients in a UK hospital: an analysis of the relative contribution of adverse drug reactions.

Coleman JJ, McDowell SE, Ferner RE.

Drug Saf. 2012 Aug 1;35(8):677-83. doi: 10.2165/11630750-000000000-00000.

PMID:
22734657
35.

Defining rewardable innovation in drug therapy.

Aronson JK, Ferner RE, Hughes DA.

Nat Rev Drug Discov. 2012 Mar 30;11(4):253-4. doi: 10.1038/nrd3715.

PMID:
22460109
36.

Medication errors.

Ferner RE.

Br J Clin Pharmacol. 2012 Jun;73(6):912-6. doi: 10.1111/j.1365-2125.2012.04236.x.

37.

A 63-year-old man with hypomagnesaemia and seizures.

Arulanantham N, Anderson M, Gittoes N, Ferner RE.

Clin Med (Lond). 2011 Dec;11(6):591-3. No abstract available.

38.

Deriving dose limits for warnings in electronic prescribing systems: statistical analysis of prescription data at University Hospital Birmingham, UK.

Coleman JJ, Hodson J, Ferner RE.

Drug Saf. 2012 Apr 1;35(4):291-8. doi: 10.2165/11594810-000000000-00000.

PMID:
22263779
39.

Biochemical monitoring of patients treated with antihypertensive therapy for adverse drug reactions: a systematic review.

McDowell SE, Ferner RE.

Drug Saf. 2011 Nov 1;34(11):1049-59. doi: 10.2165/11593980-000000000-00000. Review.

PMID:
21981433
40.

Neurofibromatosis 2: a novel risk factor for hypertension?

Hornigold RE, Golding JF, Ferner RE, Ferner RE.

Am J Med Genet A. 2011 Jul;155A(7):1721-2. doi: 10.1002/ajmg.a.34035. Epub 2011 Jun 2.

PMID:
21638762
41.

Can an electronic prescribing system detect doctors who are more likely to make a serious prescribing error?

Coleman JJ, Hemming K, Nightingale PG, Clark IR, Dixon-Woods M, Ferner RE, Lilford RJ.

J R Soc Med. 2011 May;104(5):208-18. doi: 10.1258/jrsm.2011.110061.

42.

Management of paracetamol poisoning.

Ferner RE, Dear JW, Bateman DN.

BMJ. 2011 Apr 19;342:d2218. doi: 10.1136/bmj.d2218. Review. No abstract available.

PMID:
21508044
43.
44.

Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies.

Karthikeyan VJ, Ferner RE, Baghdadi S, Lane DA, Lip GY, Beevers DG.

J Hypertens. 2011 Feb;29(2):396-9. doi: 10.1097/HJH.0b013e328341885d.

PMID:
21119533
45.

The problem of orphan drugs.

Ferner RE, Hughes DA.

BMJ. 2010 Nov 16;341:c6456. doi: 10.1136/bmj.c6456. No abstract available.

PMID:
21081597
46.

Flowers of evil.

Bonnici K, Stanworth D, Simmonds MS, Mukherjee E, Ferner RE.

Lancet. 2010 Nov 6;376(9752):1616. doi: 10.1016/S0140-6736(10)61059-8. No abstract available.

PMID:
21056765
47.

An algorithm for integrating contraindications into electronic prescribing decision support.

Ferner RE, Coleman JJ.

Drug Saf. 2010 Dec 1;33(12):1089-96. doi: 10.2165/11539390-000000000-00000.

PMID:
20961164
48.

Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.

Aronson JK, Ferner RE.

Drug Saf. 2010 Nov 1;33(11):995-1002. doi: 10.2165/11538280-000000000-00000.

PMID:
20925437
49.

Preventability of drug-related harms - part I: a systematic review.

Ferner RE, Aronson JK.

Drug Saf. 2010 Nov 1;33(11):985-94. doi: 10.2165/11538270-000000000-00000. Review.

PMID:
20925436
50.

Length of treatment. Three questions for prescribers.

Aronson JK, Ferner RE.

BMJ. 2010 Sep 15;341:c5013. doi: 10.1136/bmj.c5013. No abstract available.

PMID:
20843922

Supplemental Content

Loading ...
Support Center